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1. INTRODUCTION 
In dog thyroid shces TSH expresses most of its 
physiological effects through an increase of the 
intracellular concentration af CAMP [I]. In the sa- 
me tissue, c~bamyIcholine enhances cGMP accu- 
mulation and in TSH stimulated slices decreases 
CAMP level. These effects are reproduced by 
agents which increase free Ca2* intraceilular levels 
[2] and are abolished in calcium depleted media 
and cells [3]. The inhibition of CAMP accumulati- 
on by carbamylcholine reflects an increased dispo- 
sal rate, it is relieved by 1-methyl-3-isobutyl- 
xanthine (MIX) f4S1 but not by 
4-(3-butoxy-4-methoxybenzyI)-2-im~dazolidinone 
(Ro 20-1724). Three cyclic nucleotide phosphodi- 
esterases have been previously identified in horse 
thyroid [6]. Here, we present data suggesting that 
the effect of carbamylcholine is secondary to a di- 
rect activation by Ca” of a calmodulin-dependent 
cycfic nucleotide phosphodiesterase of dog 
thyroid. 
A h~~evjuijo~s: CAMP, adenosine 3’ ,5’-mono- 
phosphate; cCMP, guanosine 3 ’ ,~I-monopbosphate~ 
MIX, l-methyl-3-isobuty~~anthine; Ro 20-1724, 
4-(3-butoxy-4-methoxybenzyl)-2-irnidazolidinone 
2. MATERIALS AND METHODS 
CAMP and phosphod~esterase assays have been 
reported in [4,6]. The 3 soIub1e phosphodiesterases 
were separated from a 40000 x g dog thyroid crude 
supernatant [6]. Homogenization and purification 
were performed in buffers containing the following 
protease inhibitors: 75 mg/ml phenylmethyl- 
sulfonyf fluoride, 2 mM benzamidine, 5 ftM Ieu- 
peptin, 25 mgf1 trypsin inhibitor. The crude thy- 
roid supernatant was applied to a DEAE-celhdose 
column where the CAMP-specific and the cGMP- 
activated phosphodiesterases were prepared as in 
[6]. The ~~moduIin-dependent phosph~iester~e 
was obtained as in 171. After the DEAE-celluiose 
step, the calmodulin-dependent phosphodiesterase 
was applied to a c~modulin-sepharose column 
(0.9 x 10 cm) in the presence of 0.5 mM CaC12. 
The column was first washed with 40 mM 
Tris-HCl pH 7.5 buffer containing 0.5 mM CaClz 
and NaCl at two salt concentrations: 50 mM and 
200 mM. The phosphodiesterase was further eiu- 
ted with 2 mM EGTA in the presence of 200 mM 
NaCl. Calmodulin was purified from bovine brain 
as in [8]. Phenylmethylsulfony1 fluoride, benzami- 
dine, trypsin inhibitor, ~-methyl-3-isobutyl- 
xanthine were from Sigma (St Louis, MO). Leu- 
peptin was supplied by Peptide institute (Osaka). 
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DEAE-cellulose (DE-52, DE-23) was from What- 
man. Ro 20-1724 was provided by Hoffman-La 
Roche. 
CAMP hydrolysis being stimulated by 3 PM 
cGMP; the third peak specifically hydrolyzed 
CAMP. MIX and Ro 20-1724 were tested on these 
3 soluble phosphodiesterases: 
3. RESULTS (9 
The effects of Ro 20-1724 and MIX, two phos- 
phodiesterase inhibitors, have been studied on dog 
thyroid slices and on phosphodiesterases i olated 
from the same tissue. Ro 20-1724 and MIX were 
added to the incubation medium of dog thyroid sli- 
ces stimulated by TSH (1 mu/ml) in the presence 
of either 10 PM carbamylcholine or 5 pM ionopho- 
re A 23187. Table 1 shows that the decrease of 
CAMP concentration observed with carbamyl- 
choline or ionophore A 23187 was suppressed in 
the presence of 0.1 mM MIX but not with 0.1 mM 
Ro 20-1724. 
(ii) 
Three different soluble phosphodiesterases hy- 
drolyzing cGMP and/or CAMP were separated af- 
ter DEAE-cellulose chromatography (fig. 1). The 
first enzymatic peak hydrolyzed CAMP and cGMP 
and was activated by a saturated concentration of 
calmodulin in the presence of 2 mM Ca*+; the se- 
cond form also hydrolyzed both cyclic nucleotides, 
CAMP-specific phosphodiesterase was more 
sensitive to inhibition by Ro 20-1724 than to 
inhibition by MIX; this was observed in a ran- 
ge of inhibitor concentration from 
0.1 PM-100 PM (fig.2); 
The calmodulin-dependent phosphodiesterase 
was inhibited by MIX in a dose-dependent 
manner. This inhibition was much more po- 
tent than the inhibitory effect of Ro 20-1724 
(fig.3A,B). Inhibition by the xanthine was mo- 
re effective when the enzyme was studied un- 
der saturated calmodulin stimulated-assay 
conditions: at 10 PM MIX, basal phospho- 
diesterase activity was inhibited by 60%, in 
contrast activity of the enzyme stimulated by 
200 
1 
. Control 
a Lalmodulln 
0 +cychc GMP 
Table 1 
Effect of MIX and Ro 20-1724 on the 
carbamylcholine and ionophore A 23187 inhibition of 
CAMP accumulation in dog thyroid slices stimulated 
by TSH 
Ro 20-1724 MIX 
(0.1 mM) (0.1 mM) 
TSH (1 munit/ml) 2163 k 292 1575 i 42 
TSH (1 munit/ml) + 
carbamylcholine (10 ,uM) 673 k 115 1339 k 88 
TSH (1 munit/ml) + 
A 23187 (5 pM) 396 + 91 1462 k 118 
Dog thyroid slices were first incubated for 60 min in 
Krebs-Ringer-bicarbonate buffer with for the last 
20 min 5 PM ionophore A 23 187 (when tested). This was 
followed by a 30 min incubation in the presence of 
10 PM carbamylcholine, 5 PM ionophore, 1 munit/ml 
TSH and 0.1 mM Ro 20-1724 or MIX (when included). 
Results are expressed as pmol cAMP/lOO mg wet tissue 
(means of triplicates f SE). In the absence of TSH, 
CAMP accumulation reached 94 k 23 pmol/lOO mg wet 
1 5 IO 15 20 25 30 fraction wnber 
Fig. 1. Profile of dog thyroid cyclic nucleotide phospho- 
diesterase activities resolved by DEAE-cellulose chro- 
matography. Experimental details are given in section 2. 
CAMP phosphodiesterase activity was assayed at 3 PM 
substrate level in the presence of a saturated concentra- 
tion of calmodulin and 2 mM CaClz (M), or in its 
absence (M). Hydrolysis of 3 pM CAMP was also 
determined with added cGMP, 3 PM (C--O). Fractions 
of 10 ml each were collected. Activity is expressed as 
tissue pmol CAMP hydrolyzed. 20 /I-‘. 30 mini’. 
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Fig.2. Effect of MIX and Ro 20-1724 on the activity of 
dog thyroid CAMP-specific phosphodiesterase. CAMP 
hydrolysis was measured at 1 PM substrate level. Results 
are expressed as pmol CAMP hydrolyzed.min-‘.mg 
protein-‘. 
calmodulin was inhibited by 77% (fig.3A and 
3B, respectively); 
(iii) At 50pM Ro 20-1724 had no effect on the 
cGMP-activated phosphodiesterase, whereas 
MIX at the same concentration inhibited at 
about 60% CAMP hydrolysis at 3 PM substra- 
te level in the presence of 3 yM cGMP (added 
as an activator, not shown). In the absence of 
cGMP, 50 PM MIX stimulated CAMP hydro- 
lysis; this effect was described with the rat li- 
ver cGMP-stimulated phosphodiesterase [9]. 
. MIX 
, Ro 20-1724 
[ 1 
lnhtbitor M 
4. DISCUSSION 
When dog thyroid slices are stimulated by TSH, 
carbamylcholine lowers the accumulation of 
CAMP [4]. Several types of experimental data pre- 
sented earlier have suggested that the inhibition by 
carbamylcholine is mediated by an increase of the 
free intracellular Ca’+ concentration [2]. As shown 
in table 1, the effect of carbamylcholine is repro- 
duced by the ionophore A 23187 in the presence of 
Ca2+ and both controls are relieved by MIX, sug- 
gesting a common biochemical mechanism of inhi- 
bition of CAMP accumulation. Further studies 
established that the decrease of CAMP level obser- 
ved in the presence of carbamylcholine bears on 
CAMP degradation (i.e., most probably on the 
phosphodiesterases) rather than on CAMP synthe- 
sis [4]. Here, the particular effect of MIX which 
abolishes the carbamylcholine and Ca2+ effects, 
has been used in our system as a criterion to evalu- 
ate the role of the various phosphodiesterases (ta- 
ble 1). This contrasts with the negative control of 
norepinephrine on CAMP accumulation in the sa- 
me tissue which bears on CAMP synthesis (i.e., 
adenylate cyclase) and is not affected by MIX [lo]. 
We previously reported that micromolar con- 
centrations of cGMP stimulate CAMP phospho- 
diesterase activity in crude thyroid homogenate 
. MIX 
. Ro20-1724 
10-6 10-5 10-h 
I 
InhibItor M 
Fig.3. Effect of MIX and Ro 20-1724 on the activity of purified dog thyroid calmodulin-dependent phosphodiesterase 
in the absence (A), or in the presence of saturated calmodulin and 2 mM CaClz (B). CAMP hydrolysis was assayed at 
1 AM substrate level. Stimulation factors by calmodulin were 15, 13, 8 and 4-fold at 0, 5, 10 and 100/M MIX, 
respectively. Results are expressed as pmol CAMP hydrolyzed. min-’ . mg protein-‘. 
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and that this activation is no longer observed in the 
presence of 0.1 mM MIX [6]. Such data are con- 
firmed with the purified cGMP-stimulated rat liver 
phosphodiesterase [9]. Since cGMP accumulation 
is increased in the presence of carbamylcholine, 
such data argue in favor of a direct effect of cGMP 
as an activator of CAMP degradation [3]. Howe- 
ver, several indirect arguments bear against this 
hypothesis: 
MIX reduces the activation by calmodulin of a spe- 
cific phosphodiesterase which appears as the major 
catabolic enzyme for CAMP. Whether, and how 
this mechanism is general and totally independent 
of a cGMP control of the other phosphodiesterase 
is not known. A systematic investigation using 
multiple derivatives of MIX is now being carried 
out to study this problem. 
(0 
(ii) 
(iii) 
the cGMP-activated phosphodiesterase is 
clearly a Ca2+ -independent enzyme [6], and 
therefore can not be controlled directly by 
changes in intracellular Ca2+ concentration; 
Mn2+ increases cGMP without decreasing 
CAMP accumulation [2]; 
sodium nitroprusside enhances cGMP accu- 
mulation in thyroid slices whether they are de- 
pleted of Ca2+ or not; it does not decrease 
TSH induced CAMP accumulation. Moreover, 
at the same concentration, sodium nitro- 
prusside does not relieve the carbamylcholine 
inhibition of CAMP accumulation (C. De- 
caster et al., unpublished). 
We show here the presence of a calmodulin- 
dependent phosphodiesterase in dog thyroid 
(fig.1). We further show that MIX, a competitive 
inhibitor of the phosphodiesterases [I 11, is a more 
potent inhibitor of that enzyme than Ro 20-1724. 
Saturated by calmodulin, this phosphodiesterase is 
more sensitive to MIX inhibition than in its absen- 
ce, so that the factor of stimulation by calmodulin 
of the enzyme activity is progressively reduced as 
the concentration of the xanthine increases. Since 
MIX, but not Ro 20-1724, is known to suppress 
the negative control of carbamylcholine on CAMP 
accumulation, the data suggest a direct calmodulin 
activation of CAMP phosphodiesterase activity. 
The effect of the xanthine on the calmodulin- 
dependent phosphodiesterase appears to be speci- 
fic since Ro 20-1724, as in the erythrocytes [ 121, 
shows more selectivity as an inhibitor of the thy- 
roid CAMP-specific phosphodiesterase. 
In conclusion, the data obtained from the com- 
parison of MIX and Ro 20-1724 on the phospho- 
diesterase present in dog thyroid suggest that, 
when used in vitro (i.e., with thyroid slices incuba- 
ted in the presence of TSH and carbamylcholine) 
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